BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 12915596)

  • 1. High-dose therapy for patients with primary multifocal and early relapsed Ewing's tumors: results of two consecutive regimens assessing the role of total-body irradiation.
    Burdach S; Meyer-Bahlburg A; Laws HJ; Haase R; van Kaik B; Metzner B; Wawer A; Finke R; Göbel U; Haerting J; Pape H; Gadner H; Dunst J; Juergens H
    J Clin Oncol; 2003 Aug; 21(16):3072-8. PubMed ID: 12915596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [High-dosage chemotherapy in primary metastasized and relapsed Ewing's sarcoma. (EI)CESS].
    Fröhlich B; Ahrens S; Burdach S; Klingebiel T; Ladenstein R; Paulussen M; Zoubek A; Jürgens H
    Klin Padiatr; 1999; 211(4):284-90. PubMed ID: 10472563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does consolidation with autologous stem cell transplantation improve the outcome of children with metastatic or relapsed Ewing sarcoma?
    Al-Faris N; Al Harbi T; Goia C; Pappo A; Doyle J; Gassas A
    Pediatr Blood Cancer; 2007 Aug; 49(2):190-5. PubMed ID: 17262797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of high-dose busulfan plus melphalan as consolidation in metastatic Ewing tumors: a study by the Société Française des Cancers de l'Enfant.
    Oberlin O; Rey A; Desfachelles AS; Philip T; Plantaz D; Schmitt C; Plouvier E; Lejars O; Rubie H; Terrier P; Michon J;
    J Clin Oncol; 2006 Aug; 24(24):3997-4002. PubMed ID: 16921053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Total body MRI-governed involved compartment irradiation combined with high-dose chemotherapy and stem cell rescue improves long-term survival in Ewing tumor patients with multiple primary bone metastases.
    Burdach S; Thiel U; Schöniger M; Haase R; Wawer A; Nathrath M; Kabisch H; Urban C; Laws HJ; Dirksen U; Steinborn M; Dunst J; Jürgens H;
    Bone Marrow Transplant; 2010 Mar; 45(3):483-9. PubMed ID: 19684633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Results of the EICESS-92 Study: two randomized trials of Ewing's sarcoma treatment--cyclophosphamide compared with ifosfamide in standard-risk patients and assessment of benefit of etoposide added to standard treatment in high-risk patients.
    Paulussen M; Craft AW; Lewis I; Hackshaw A; Douglas C; Dunst J; Schuck A; Winkelmann W; Köhler G; Poremba C; Zoubek A; Ladenstein R; van den Berg H; Hunold A; Cassoni A; Spooner D; Grimer R; Whelan J; McTiernan A; Jürgens H;
    J Clin Oncol; 2008 Sep; 26(27):4385-93. PubMed ID: 18802150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved relapse free survival in patients with poor prognosis Ewing's sarcoma after consolidation with hyperfractionated total body irradiation and fractionated high dose melphalan followed by high dose etoposide and hematopoietic rescue.
    Burdach S; Peters C; Paulussen M; Nürnberger W; Wurm R; Wernet P; Dilloo D; Voehringer R; Gadner H; Göbel U
    Bone Marrow Transplant; 1991; 7 Suppl 2():95. PubMed ID: 1678978
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of metastatic Ewing's sarcoma or primitive neuroectodermal tumor of bone: evaluation of combination ifosfamide and etoposide--a Children's Cancer Group and Pediatric Oncology Group study.
    Miser JS; Krailo MD; Tarbell NJ; Link MP; Fryer CJ; Pritchard DJ; Gebhardt MC; Dickman PS; Perlman EJ; Meyers PA; Donaldson SS; Moore S; Rausen AR; Vietti TJ; Grier HE
    J Clin Oncol; 2004 Jul; 22(14):2873-6. PubMed ID: 15254055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Definitive irradiation in multidisciplinary management of localized Ewing sarcoma family of tumors in pediatric patients: outcome and prognostic factors.
    Krasin MJ; Rodriguez-Galindo C; Billups CA; Davidoff AM; Neel MD; Merchant TE; Kun LE
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):830-8. PubMed ID: 15465200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term event-free survival after intensive chemotherapy for Ewing's family of tumors in children and young adults.
    Kolb EA; Kushner BH; Gorlick R; Laverdiere C; Healey JH; LaQuaglia MP; Huvos AG; Qin J; Vu HT; Wexler L; Wolden S; Meyers PA
    J Clin Oncol; 2003 Sep; 21(18):3423-30. PubMed ID: 12972518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Long-term results following multidisciplinary treatment of localized Ewing's sarcoma in children and adolescents].
    Ullmann C; Beck JD; Holter W; Petsch S; Dunst J; Sauer R; Grabenbauer GG
    Strahlenther Onkol; 2008 Mar; 184(3):137-44. PubMed ID: 18330509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [EICESS 92 (European Intergroup Cooperative Ewing's Sarcoma Study)-- preliminary results].
    Paulussen M; Ahrens S; Braun-Munzinger G; Craft AW; Dockhorn-Dworniczak B; Dörffel W; Dunst J; Fröhlich B; Göbel U; Häussler M; Klingebiel T; Koscielniak E; Mittler U; Rübe C; Winkelmann W; Voûte PA; Zoubek A; Jürgens H
    Klin Padiatr; 1999; 211(4):276-83. PubMed ID: 10472562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How effective is dose-intensive/myeloablative therapy against Ewing's sarcoma/primitive neuroectodermal tumor metastatic to bone or bone marrow? The Memorial Sloan-Kettering experience and a literature review.
    Kushner BH; Meyers PA
    J Clin Oncol; 2001 Feb; 19(3):870-80. PubMed ID: 11157041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Megachemotherapy followed by autologous stem cell transplantation in children with Ewing's sarcoma.
    Drabko K; Zawitkowska-Klaczynska J; Wojcik B; Choma M; Zaucha-Prazmo A; Kowalczyk J; Gorczynska E; Toporski J; Kałwak K; Turkiewicz D; Chybicka A
    Pediatr Transplant; 2005 Oct; 9(5):618-21. PubMed ID: 16176419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiation therapy for Ewing's sarcoma: results from Memorial Sloan-Kettering in the modern era.
    La TH; Meyers PA; Wexler LH; Alektiar KM; Healey JH; Laquaglia MP; Boland PJ; Wolden SL
    Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):544-50. PubMed ID: 16198063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose busulphan/melphalan with autologous stem cell rescue in Ewing's sarcoma.
    Atra A; Whelan JS; Calvagna V; Shankar AG; Ashley S; Shepherd V; Souhami RL; Pinkerton CR
    Bone Marrow Transplant; 1997 Nov; 20(10):843-6. PubMed ID: 9404924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Neoadjuvant treatment of Ewing's sarcoma: results obtained in 122 patients treated with a 6-drug chemotherapeutic protocol (vincristine, adriamycin, cyclophosphamide, dactinomycin, ifosfamide and etoposide)].
    Bacci G; Ferrari S; Rosito P; Barbieri E; Mercuri M; Brach del Prever A; Iantorno D; Forni C; Campanacci M
    Minerva Pediatr; 1995 Nov; 47(11):457-69. PubMed ID: 8684341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tandem high-dose chemotherapy followed by autologous transplantation in patients with locally advanced or metastatic sarcoma.
    Lashkari A; Chow WA; Valdes F; Leong L; Phan V; Twardowski P; Kapoor N; Molina A; Al-Kadhimi Z; Frankel P; Somlo G
    Anticancer Res; 2009 Aug; 29(8):3281-8. PubMed ID: 19661346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiotherapy in Ewing tumors of the vertebrae: treatment results and local relapse analysis of the CESS 81/86 and EICESS 92 trials.
    Schuck A; Ahrens S; von Schorlemer I; Kuhlen M; Paulussen M; Hunold A; Gosheger G; Winkelmann W; Dunst J; Willich N; Jürgens H
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1562-7. PubMed ID: 16137838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose melphalan, etoposide, total-body irradiation, and autologous stem-cell reconstitution as consolidation therapy for high-risk Ewing's sarcoma does not improve prognosis.
    Meyers PA; Krailo MD; Ladanyi M; Chan KW; Sailer SL; Dickman PS; Baker DL; Davis JH; Gerbing RB; Grovas A; Herzog CE; Lindsley KL; Liu-Mares W; Nachman JB; Sieger L; Wadman J; Gorlick RG
    J Clin Oncol; 2001 Jun; 19(11):2812-20. PubMed ID: 11387352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.